Upstate Active Clinical Trials
Study Title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care. 230LE303Upstate Institutional Review Board (IRB) Number:
1826645Study/Protocol ID:
230LE303Patient Age Group:
AdultsPrincipal Investigator:
Andras Perl, MD, PhDWho can I contact for more information?
Name: Joanne M Chilton, CCRP
Phone: 315-464-8240
Email: chiltonj@upstate.edu